Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Bottari

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Trends in Pharmacological Sciences|September 1, 1992
Angiotensin receptor subtypes in the brainU M Steckelings, S P Bottari, T Unger
Receptors & Channels|January 1, 1994
Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanismV Brechler, S Reichlin, M De Gasparo, et al.
Endocrine Research|February 1, 1995
Stimulation of cortisol production through angiotensin AT2 receptors in bovine fasciculata cellsG Defaye, S Lecomte, E M Chambaz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1987
Oxytocin and vasopressin: distinct receptors in myometriumG Guillon, M N Balestre, J M Roberts, et al.
Receptors & Channels|January 1, 1994
Angiotensin AT2 receptor mediated inhibition of particulate guanylate cyclase: a link with protein tyrosine phosphatase stimulation?V Brechler, N R Levens, M De Gasparo, et al.
Molecular and Cellular Endocrinology|August 30, 1996
The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cellsS Meffert, M Stoll, U M Steckelings, et al.
The American Journal of Physiology|November 14, 1997
ANG II AT1 and AT2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cellsP Liakos, N Bourmeyster, G Defaye, et al.
Pharmacology & Toxicology|October 1, 1992
Could the pharmacological differences observed between angiotensin II antagonists and inhibitors of angiotensin converting enzyme be clinically beneficial?N R Levens, M de Gasparo, J M Wood, et al.
Frontiers in Neuroendocrinology|April 1, 1993
Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implicationsS P Bottari, M de Gasparo, U M Steckelings, et al.
Endocrinology|March 1, 1995
Hormonal regulation of mitogen-activated protein kinase activity in bovine adrenocortical cells: cross-talk between phosphoinositides, adenosine 3',5'-monophosphate, and tyrosine kinase receptor pathwaysO Chabre, F Cornillon, S P Bottari, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Trends in Pharmacological Sciences|September 1, 1992
Angiotensin receptor subtypes in the brainU M Steckelings, S P Bottari, T Unger
Receptors & Channels|January 1, 1994
Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanismV Brechler, S Reichlin, M De Gasparo, et al.
Endocrine Research|February 1, 1995
Stimulation of cortisol production through angiotensin AT2 receptors in bovine fasciculata cellsG Defaye, S Lecomte, E M Chambaz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1987
Oxytocin and vasopressin: distinct receptors in myometriumG Guillon, M N Balestre, J M Roberts, et al.
Receptors & Channels|January 1, 1994
Angiotensin AT2 receptor mediated inhibition of particulate guanylate cyclase: a link with protein tyrosine phosphatase stimulation?V Brechler, N R Levens, M De Gasparo, et al.
Molecular and Cellular Endocrinology|August 30, 1996
The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cellsS Meffert, M Stoll, U M Steckelings, et al.
The American Journal of Physiology|November 14, 1997
ANG II AT1 and AT2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cellsP Liakos, N Bourmeyster, G Defaye, et al.
Pharmacology & Toxicology|October 1, 1992
Could the pharmacological differences observed between angiotensin II antagonists and inhibitors of angiotensin converting enzyme be clinically beneficial?N R Levens, M de Gasparo, J M Wood, et al.
Frontiers in Neuroendocrinology|April 1, 1993
Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implicationsS P Bottari, M de Gasparo, U M Steckelings, et al.
Endocrinology|March 1, 1995
Hormonal regulation of mitogen-activated protein kinase activity in bovine adrenocortical cells: cross-talk between phosphoinositides, adenosine 3',5'-monophosphate, and tyrosine kinase receptor pathwaysO Chabre, F Cornillon, S P Bottari, et al.
Pageof 3